Document is current
Any future updates will be listed below
-
Authors
Büyücek, Seyma
Möller, Katharina
Viehweger, Florian
Schlichter, Ria
Menz, Anne
Luebke, Andreas M
Reiswich, Viktor
Kluth, Martina
Hube-Magg, Claudia
Hinsch, Andrea
Lutz, Florian
Weidemann, Sören
Jacobsen, Frank
Lennartz, Maximilian
Dum, David
Bernreuther, Christian
Lebok, Patrick
Sauter, Guido
Marx, Andreas H
Simon, Ronald
Fraune, Christoph
Gorbokon, Natalia
Burandt, Eike
Minner, Sarah
Steurer, Stefan
Clauditz, Till S
Krech, Till
Chirico, Viktoria
-
Funding
Funding for this research was provided by:
Universitätsklinikum Hamburg-Eppendorf (UKE)
- License Information
-
More Information
Article History
Received: 18 November 2024
Accepted: 29 December 2025
First Online: 10 January 2026
Declarations
:
: The local ethics committee (Ethics Commission Hamburg, WF-049/09) has approved the manufacturing and analysis of TMAs from archived remnants of diagnostic tissues. Patientsdata analysis without informed patient consent is covered by local laws (HmbKHG, § 12).The use of archived remnants of diagnostic tissues for manufacturing of TMAs and their analysis for research purposes as well as patient data analysis has been approved by local laws (HmbKHG, § 12) and by the local ethics committee (Ethics Commission Hamburg, WF-049/09). All work has been carried out in compliance with the Helsinki.
: Not applicable.
: The rabbit recombinant GLUT1 antibody, clone MSVA-401R was provided from MS Validated Antibodies GmbH, Hamburg, Germany (owned by a family member of GS).
